SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-16-037360
Filing Date
2016-08-15
Accepted
2016-08-15 07:02:26
Documents
23
Period of Report
2016-08-15
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20160812_8k.htm 8-K 29901
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 12036
3 EXHIBIT 99.2 ex99-2.htm EX-99.2 21273
4 b1.jpg GRAPHIC 8807
5 a19.jpg GRAPHIC 56827
6 a18.jpg GRAPHIC 144202
7 a17.jpg GRAPHIC 132922
8 a16.jpg GRAPHIC 91363
9 a15.jpg GRAPHIC 77412
10 a14.jpg GRAPHIC 76615
11 a13.jpg GRAPHIC 98994
12 a12.jpg GRAPHIC 93388
13 a11.jpg GRAPHIC 141100
14 a10.jpg GRAPHIC 135322
15 a9.jpg GRAPHIC 108143
16 a8.jpg GRAPHIC 95509
17 a7.jpg GRAPHIC 92597
18 a6.jpg GRAPHIC 107201
19 a5.jpg GRAPHIC 123471
20 a4.jpg GRAPHIC 139824
21 a3.jpg GRAPHIC 104560
22 a2.jpg GRAPHIC 173251
23 a1.jpg GRAPHIC 78717
  Complete submission text file 0001437749-16-037360.txt   2930847
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 161829939
SIC: 2834 Pharmaceutical Preparations